Yahoo Finance and Antares Pharma: A Look

Yahoo Finance is a popular platform for tracking financial data, news, and insights related to stocks, bonds, currencies, and other investment instruments. When searching for “Antares” on Yahoo Finance, users are typically directed to information about Antares Pharma, Inc. (ATRS). However, since Antares Pharma was acquired by Halozyme Therapeutics, Inc. in 2022, its stock ticker (ATRS) is no longer actively traded on major exchanges. Understanding the historical context is crucial when interpreting information found on Yahoo Finance regarding Antares.

Antares Pharma (Historical Context)

Antares Pharma was a specialty pharmaceutical company focused on developing and commercializing self-injection pharmaceutical products and technologies. Their proprietary drug delivery systems, including reusable and disposable auto-injectors, played a key role in their portfolio. Key products included:

• Xyosted: A testosterone enanthate injection for hypogonadism.
• Nokomis: An auto-injector platform technology.
• Other partnered products: Antares collaborated with other pharmaceutical companies to develop and commercialize auto-injector versions of their drugs.

The company’s focus on self-injection technologies positioned them as a key player in improving patient adherence and convenience in administering medications for various conditions. This specialization made them an attractive acquisition target.

Yahoo Finance’s Role

Historically, Yahoo Finance provided comprehensive information about Antares Pharma (ATRS), including:

• Stock Price: Real-time or delayed stock prices, historical charts, and trading volume data.
• Financial Statements: Income statements, balance sheets, and cash flow statements.
• Analyst Ratings: Ratings and price targets from Wall Street analysts.
• News & Headlines: Relevant news articles and press releases related to the company.
• Company Profile: Information about the company’s business operations, management team, and competitors.

While the ATRS ticker is no longer actively traded, Yahoo Finance may still retain historical data and news articles related to Antares Pharma for archival purposes. Users searching for “Antares Pharma” should be aware that this information reflects the company’s performance and status before its acquisition by Halozyme.

Post-Acquisition Considerations

Following the acquisition, Antares Pharma became a subsidiary of Halozyme Therapeutics (HALO). Investors interested in the assets and technologies formerly held by Antares should now focus on Halozyme Therapeutics. Yahoo Finance provides detailed information about HALO, including its stock performance, financial statements, and news coverage.

When researching past investments or acquisitions, it is essential to understand the timeline of events. Although Antares Pharma no longer exists as a publicly traded entity, its history and contributions to the pharmaceutical industry remain relevant. Yahoo Finance can be a valuable tool for accessing this historical data, but it’s important to interpret it within the context of the acquisition by Halozyme.

In conclusion, while “Antares” on Yahoo Finance once directed users to Antares Pharma (ATRS), the stock is no longer active. Researchers should focus on Halozyme Therapeutics (HALO) for information pertaining to the acquired assets and refer to archived data for historical context on Antares Pharma’s independent operations.